• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    4/4/24 1:21:21 PM ET
    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ABIO alert in real time by email

    Shares of STAAR Surgical Company (NASDAQ:STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance.

    STAAR Surgical shares jumped 13.3% to $44.30 on Thursday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • TC Biopharm (Holdings) Plc (NASDAQ:TCBP) shares climbed 130.1% to $2.9790. TCBP announced execution of non-binding letter of intent for acquisition of NK Platform Technologies.
    • Allurion Technologies Inc. (NASDAQ:ALUR) gained 70% to $2.8801 after the company announced the commercial availability of its Virtual Care Suite in the United States. Also, Chardan Capital initiated coverage on the stock with a Buy rating and announced a $5 price target.
    • Tevogen Bio Holdings Inc. (NASDAQ:TVGN) shares climbed 40.6% to $3.58. Tevogen Bio, on Wednesday, appointed Tapan V Shah as Head of Investor Relations and Corporate Development.
    • HWH International Inc. (NASDAQ:HWH) gained 38.8% to $2.1765.
    • Candel Therapeutics, Inc. (NASDAQ:CADL) rose 36.3% to $2.2899 after the company announced interim data from the randomized phase 2 clinical trial of CAN-2409 in non-metastatic prostate cancer.
    • MacroGenics, Inc. (NASDAQ:MGNX) climbed 27.8% to $17.47. MacroGenics announced TAMARACK study data will not be presented at the ASCO Annual Meeting.
    • E-Home Household Service Holdings Limited (NASDAQ:EJH) gained 27% to $2.22.
    • Reliance Global Group, Inc. (NASDAQ:RELI) gained 24.6% to $0.46 after the company reported FY23 earnings.
    • Simulations Plus, Inc. (NASDAQ:SLP) rose 22.5% to $47.12 after the company posted better-than-expected results for its second quarter.
    • Vast Renewables Limited (NASDAQ:VSTE) gained 22.3% to $8.81.
    • Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH) gained 21.3% to $3.7950 following a narrower-than-expected quarterly loss.
    • Gorilla Technology Group Inc. (NASDAQ:GRRR) jumped 19% to $0.8729 after the company reported a year-over-year increase in FY23 sales results.
    • Levi Strauss & Co. (NYSE:LEVI) shares rose 18.3% to $22.10 after the company reported upbeat earnings for its first quarter and boosted its 2024 earnings guidance.
    • NOVONIX Limited (NYSE:NVX) gained 15.4% to $2.83.
    • Zeta Global Holdings Corp. (NYSE:ZETA) climbed 14.8% to $12.09 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised its price target from $12 to $17.
    • Graphjet Technology (NASDAQ:GTI) gained 13.3% to $8.17
    • MaxLinear, Inc. (NASDAQ:MXL) gained 11.8% to $24.22. MaxLinear is expected to release its financial results for the first quarter 2024 after the closing bell on April 24, 2024.
    • Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) gained 9.7% to $1.81. Eiger Biopharmaceuticals said on April 2, it received a notice from the Nasdaq that the company’s common stock will be delisted from Nasdaq.
    • Destiny Tech100 Inc. (NASDAQ:DXYZ) shares gained 8.8% to $29.39 after jumping 27% on Wednesday.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) shares rose 8.2% to $16.76. Addex Therapeutics shares gained 18% on Wednesday after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix..
    • MicroStrategy Incorporated (NASDAQ:MSTR) gained 7.4% to $1,724.42 amid a rise in Bitcoin.
    • Enphase Energy, Inc. (NASDAQ:ENPH) climbed 7% to $126.86.
    • HubSpot, Inc. (NYSE:HUBS) gained 6% to $664.51 following a report suggesting Alphabet is in talks with advisors about a potential offer for the company.
    • BlackBerry Limited (NYSE:BB) climbed 4% to $2.9223 after the company reported fourth-quarter results and issued FY25 guidance.

    Losers

    • eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) shares dipped 80.7% to $3.1801. The company announced topline results from the primary analysis of the randomized Phase 2 KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer.
    • Keyarch Acquisition Corporation (NASDAQ:KYCH) fell 34.5% to $5.94.
    • View, Inc. (NASDAQ:VIEW) fell 29.4% to $0.3601. View shares fell on Wednesday after the company filed for Chapter 11 bankruptcy.
    • Achilles Therapeutics plc (NASDAQ:ACHL) declined 27% to $0.88 after the company reported fourth-quarter financial results. The company announced interim Phase I/IIa data on the use of clonal neoantigen reactive T cells from the CHIRON study in advanced unresectable or metastatic non-small cell lung cancer and the THETIS study in recurrent or metastatic malignant melanoma.
    • KWESST Micro Systems Inc. (NASDAQ:KWE) fell 24.4% to $0.85 after the company announced a proposed US public offering.
    • AXT, Inc. (NASDAQ:AXTI) fell 22.2% to $3.85. Traders circulated J Capital short report.
    • XTI Aerospace, Inc. (NASDAQ:XTIA) fell 20.9% to $3.64 after gaining 31% on Wednesday.
    • DigiAsia Corp. (NASDAQ:FAAS) fell 20% to $5.37.
    • Lamb Weston Holdings, Inc. (NYSE:LW) declined 17.5% to $83.40 after the company reported weak third-quarter results and cut its FY24 outlook.
    • Selina Hospitality PLC (NASDAQ:SLNA) dipped 17.5% to $0.0811.
    • Casa Systems, Inc. (NASDAQ:CASA) declined 16.3% to $0.0460. Casa Systems said the company and some units entered into asset purchase agreement with Lumine providing for sale and purchase of debtors' Cloud/Ran APA assets.
    • Kintara Therapeutics, Inc. (NASDAQ:KTRA) fell 15.2% to $0.1390. Kintara Therapeutics recently entered a merger agreement with TuHURA Biosciences.
    • Flora Growth Corp. (NASDAQ:FLGC) fell 13.5% to $2.3095 after the company reported the launch of proposed underwritten public offering of common shares.
    • GCT Semiconductor Holding, Inc. (NYSE:GCTS) fell 13.1% to $5.96.
    • SolarMax Technology, Inc. (NASDAQ:SMXT) dipped 10.9% to $11.75.
    • LAMF Global Ventures Corp. I (NASDAQ:LGVC) shares tumbled 10.2% to $9.97. LAMF Global Ventures Corp. I shares gained 3% on Wednesday after the company announced shareholders approved the previously announced business combination with Nuvo.
    • ARCA biopharma, Inc. (NASDAQ:ABIO) fell 8.9% to $2.96. ARCA Biopharma shares jumped 90% on Wednesday after the company and Oruka Therapeutics announced a merger agreement.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) fell 8.9% to $3.9850 after the company filed for an up to $250 million mixed shelf offering.
    • OneMedNet Corporation (NASDAQ:ONMD) shares fell 8.6% to $0.97. OneMedNet shares jumped 34% on Wednesday after the company completed a securities purchase agreement to provide up to $4.54 million in funding.
    • Rent the Runway, Inc. (NASDAQ:RENT) fell 8.6% to $5.37.
    • Paramount Global (NASDAQ:PARA) fell 8.2% to $12.40 following a report suggesting the Ellison-led bid would require the company to raise new equity.

     

    Now Read This: Bitcoin Tops $66,000 Following Jobless Claims Data; Ethena Emerges As Top Gainer

    Get the next $ABIO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABIO
    $ACHL
    $ADXN
    $ALUR

    CompanyDatePrice TargetRatingAnalyst
    MaxLinear Inc.
    $MXL
    4/24/2026$60.00Neutral → Buy
    Roth Capital
    Aquestive Therapeutics Inc.
    $AQST
    4/24/2026$8.00Outperform
    Oppenheimer
    MaxLinear Inc.
    $MXL
    4/24/2026$60.00Hold → Buy
    Needham
    Candel Therapeutics Inc.
    $CADL
    4/20/2026Overweight
    Cantor Fitzgerald
    MacroGenics Inc.
    $MGNX
    4/10/2026$9.00Neutral → Buy
    B. Riley Securities
    STAAR Surgical Company
    $STAA
    4/9/2026$27.00Hold → Buy
    Canaccord Genuity
    HubSpot Inc.
    $HUBS
    3/31/2026$300.00Buy
    BofA Securities
    Strategy Inc
    $MSTR
    3/10/2026$175.00Buy
    B. Riley Securities
    More analyst ratings

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MaxLinear upgraded by Roth Capital with a new price target

    Roth Capital upgraded MaxLinear from Neutral to Buy and set a new price target of $60.00

    4/24/26 8:33:10 AM ET
    $MXL
    Semiconductors
    Technology

    Oppenheimer resumed coverage on Aquestive Therapeutics with a new price target

    Oppenheimer resumed coverage of Aquestive Therapeutics with a rating of Outperform and set a new price target of $8.00

    4/24/26 8:31:20 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MaxLinear upgraded by Needham with a new price target

    Needham upgraded MaxLinear from Hold to Buy and set a new price target of $60.00

    4/24/26 8:00:47 AM ET
    $MXL
    Semiconductors
    Technology

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    SEC Filings

    View All

    SEC Form S-8 filed by NOVONIX Limited

    S-8 - NOVONIX Ltd (0001859795) (Filer)

    4/24/26 9:41:40 AM ET
    $NVX
    Industrial Machinery/Components
    Miscellaneous

    SEC Form S-8 filed by NOVONIX Limited

    S-8 - NOVONIX Ltd (0001859795) (Filer)

    4/24/26 7:43:33 AM ET
    $NVX
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 10-Q filed by MaxLinear Inc.

    10-Q - MAXLINEAR, INC (0001288469) (Filer)

    4/23/26 4:13:32 PM ET
    $MXL
    Semiconductors
    Technology

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MARGENZA issued to MACROGENICS INC

    Submission status for MACROGENICS INC's drug MARGENZA (SUPPL-5) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 05/25/2023. Application Category: BLA, Application Number: 761150, Application Classification:

    5/29/23 4:45:45 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MARGENZA

    Submission status for MACROGENICS INC's drug MARGENZA (ORIG-1) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 12/16/2020. Application Category: BLA, Application Number: 761150, Application Classification:

    12/20/20 4:31:01 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Yu Jeffrey was granted 219,429 shares and bought $750,000 worth of shares (903,614 units at $0.83), increasing direct ownership by 15% to 8,449,266 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    4/24/26 8:40:21 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Director Kosasa Thomas bought $749,999 worth of shares (876,136 units at $0.86), increasing direct ownership by 6% to 16,661,327 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    4/24/26 8:40:19 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Director Halligan Brian sold $1,913,130 worth of shares (8,292 units at $230.72) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 362,000 units (SEC Form 4)

    4 - HUBSPOT INC (0001404655) (Issuer)

    4/23/26 4:44:33 PM ET
    $HUBS
    Computer Software: Prepackaged Software
    Technology

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Yu Jeffrey was granted 219,429 shares and bought $750,000 worth of shares (903,614 units at $0.83), increasing direct ownership by 15% to 8,449,266 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    4/24/26 8:40:21 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Director Kosasa Thomas bought $749,999 worth of shares (876,136 units at $0.86), increasing direct ownership by 6% to 16,661,327 units (SEC Form 4)

    4 - OneMedNet Corp (0001849380) (Issuer)

    4/24/26 8:40:19 AM ET
    $ONMD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Director Broadwood Partners, L.P. bought $12,266,545 worth of shares (670,213 units at $18.30) (SEC Form 4)

    4 - STAAR SURGICAL CO (0000718937) (Issuer)

    3/13/26 7:59:59 PM ET
    $STAA
    Ophthalmic Goods
    Health Care

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AXT Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

    AXT, Inc. (NASDAQ:AXTI) ("AXT" or the "Company"), a leading manufacturer of compound semiconductor wafer substrates, announced today that, in connection with its recently completed underwritten public offering of 8,560,311 shares of common stock, the underwriters have exercised their over-allotment option to purchase an additional 1,284,046 shares of common stock at a price to the public of $64.25 for additional gross proceeds of approximately $82.5 million, before deducting underwriting discounts and commissions and other offering expenses. As previously announced, the Company intends to use the net proceeds from the offering primarily to financially support our subsidiary Beijing Tongme

    4/24/26 12:00:00 PM ET
    $AXTI
    Semiconductors
    Technology

    Tradr Launches Leveraged ETFs on AXTI, CPNG, MPWR and STX

    Listings cover stocks involved in trending themes such as data storage and AI compute infrastructure Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched four new leveraged ETFs on single stocks. The Cboe-listed funds seek to deliver two times long (200%) the daily performance of a specific underlying stock. Three of the four ETFs are first-to-market strategies. The following ETFs are expected to open for trading today: Tradr 2X Long AXTI Daily ETF (Cboe: AXTX) – tracks AXT Inc. (NASDAQ:AXTI) Tradr 2X Long CPNG Daily ETF (Cboe: CPNX) – tracks Coupang Inc. (NYSE:CPNG) Tradr 2X Long MPWR Daily ETF (Cboe: MPWX) – tracks Monol

    4/24/26 6:46:00 AM ET
    $AXTI
    $CPNG
    $MPWR
    Semiconductors
    Technology
    Catalog/Specialty Distribution
    Consumer Discretionary

    HubSpot to Announce First Quarter 2026 Financial Results on May 7, 2026

    HubSpot, the agentic customer platform for scaling businesses, announced today that it will report its first quarter 2026 financial results after the U.S. financial markets close on Thursday, May 7, 2026. In conjunction with this report, HubSpot will host a conference call at 4:30 p.m. Eastern Time (ET) on the same day to discuss the company's first quarter 2026 financial results and its business operations and outlook. HubSpot First Quarter 2026 Financial Results When: Thursday, May 7, 2026 Time: 4:30 p.m. ET Conference Call Registration: Dial-in Link Webcast: Webcast Link To participate via telephone, please register in advance. Upon registration, participants will receive a confirma

    4/23/26 4:05:00 PM ET
    $HUBS
    Computer Software: Prepackaged Software
    Technology

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Leadership Updates

    Live Leadership Updates

    View All

    Gorilla Technology Increases Strategic Investment in Astrikos.AI

    - Builds on Q4 investment to further advance Gorilla's integrated AI infrastructure strategy across India, USA, and UAE- Appoints Managing Partner of Gorilla Tech Capital to the board of AstrikosLondon, United Kingdom--(Newsfile Corp. - April 15, 2026) - Gorilla Technology Group Inc. (NASDAQ:GRRR) ("Gorilla" or the "Company"), a global solution provider in AI-driven Security Intelligence, Network Intelligence, Business Intelligence and IoT technology, today announced that it has increased its strategic investment in Astrikos.AI ("Astrikos"), the Bengaluru, India-based, real-time infrastructure intelligence company, deepening the operational and commercial relationship betw

    4/15/26 8:30:00 AM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    HubSpot Announces Mike Berry Joins Board of Directors

    HubSpot, Inc. (NYSE:HUBS), the agentic customer platform for scaling companies, announced today that Mike Berry, Chief Financial Officer of MongoDB, has been appointed to the company's Board of Directors, effective April 1, 2026. Berry brings more than 30 years of experience in finance, operations, and general management across the technology industry, with a track record of driving profitable growth at leading public technology companies. Berry joins HubSpot's board as the company continues to scale its operations and deepen its financial discipline across global markets. As CFO of MongoDB, Berry oversees the company's global finance organization, including financial strategy, planning

    4/1/26 4:10:00 PM ET
    $HUBS
    Computer Software: Prepackaged Software
    Technology

    Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer

    Thomas A. Zalewski, a Partner at Day Pitney LLP, appointed Chief Legal Officer and Chief Compliance Officer effective April 2, 2026Lori J. Braender to remain in a non-executive role as Corporate Secretary after nearly eight years as Chief Legal Officer, Chief Compliance Officer and Corporate Secretary WARREN, N.J., March 20, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer, effective Apr

    3/20/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Financials

    Live finance-specific insights

    View All

    HubSpot to Announce First Quarter 2026 Financial Results on May 7, 2026

    HubSpot, the agentic customer platform for scaling businesses, announced today that it will report its first quarter 2026 financial results after the U.S. financial markets close on Thursday, May 7, 2026. In conjunction with this report, HubSpot will host a conference call at 4:30 p.m. Eastern Time (ET) on the same day to discuss the company's first quarter 2026 financial results and its business operations and outlook. HubSpot First Quarter 2026 Financial Results When: Thursday, May 7, 2026 Time: 4:30 p.m. ET Conference Call Registration: Dial-in Link Webcast: Webcast Link To participate via telephone, please register in advance. Upon registration, participants will receive a confirma

    4/23/26 4:05:00 PM ET
    $HUBS
    Computer Software: Prepackaged Software
    Technology

    Zeta Global to Announce First Quarter 2026 Results on April 30, 2026

    Zeta Global (NYSE:ZETA), the AI Marketing Cloud, today announced the planned release of its first quarter 2026 financial results after the market close on Thursday, April 30, 2026. Co-Founder, Chairman, and CEO David A. Steinberg and CFO Chris Greiner will host a conference call later that day, at 4:30 p.m. Eastern Time. A live webcast and replay of the conference call will be accessible on Zeta's Investor Relations website at http://investors.zetaglobal.com where it will remain available for one year. About Zeta Global Zeta Global (NYSE:ZETA) is the AI Marketing Cloud that leverages advanced artificial intelligence (AI) and trillions of consumer signals to make it easier for marketers

    4/16/26 4:05:00 PM ET
    $ZETA
    Computer Software: Prepackaged Software
    Technology

    XTI Aerospace Reports Fourth Quarter and Full Year 2025 Results

    DALLAS, April 15, 2026 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ:XTIA) ("XTI Aerospace," "XTI," or the "Company"), a publicly traded aerospace and defense company operating across drone distribution, unmanned systems, and advanced manufacturing markets through three dedicated divisions, and parent company of Drone Nerds, LLC, a leading drone solutions platform serving enterprise and government customers, today announced financial results for its fourth quarter and full year ended December 31, 2025, and provided the Company's outlook for 2026. 2025 fourth quarter and full year

    4/15/26 8:50:00 AM ET
    $UMAC
    $XTIA
    Radio And Television Broadcasting And Communications Equipment
    Technology
    EDP Services

    $ABIO
    $ACHL
    $ADXN
    $ALUR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Candel Therapeutics Inc.

    SC 13G - Candel Therapeutics, Inc. (0001841387) (Subject)

    12/17/24 12:30:40 PM ET
    $CADL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care